Search

Sergio Coffa

Examiner (ID: 9524, Phone: (571)270-3022 , Office: P/1675 )

Most Active Art Unit
1658
Art Unit(s)
1676, 1658, 1654, 1675
Total Applications
897
Issued Applications
440
Pending Applications
134
Abandoned Applications
351

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16892080 [patent_doc_number] => 11033607 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-15 [patent_title] => Peptides and methods for preventing ischemic tissue injury [patent_app_type] => utility [patent_app_number] => 14/438375 [patent_app_country] => US [patent_app_date] => 2013-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 8093 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14438375 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/438375
Peptides and methods for preventing ischemic tissue injury Oct 27, 2013 Issued
Array ( [id] => 9757311 [patent_doc_number] => 20140288012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-25 [patent_title] => 'METHODS FOR THE PREVENTION AND TREATMENT OF BURN INJURIES AND SECONDARY COMPLICATIONS' [patent_app_type] => utility [patent_app_number] => 14/061370 [patent_app_country] => US [patent_app_date] => 2013-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 18293 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14061370 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/061370
Methods for the prevention and treatment of burn injuries and secondary complications Oct 22, 2013 Issued
Array ( [id] => 10361087 [patent_doc_number] => 20150246092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-03 [patent_title] => 'METHODS FOR REDUCING RISKS ASSOCIATED WITH HEART FAILURE AND FACTORS ASSOCIATED THEREWITH' [patent_app_type] => utility [patent_app_number] => 14/437325 [patent_app_country] => US [patent_app_date] => 2013-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 34233 [patent_no_of_claims] => 117 [patent_no_of_ind_claims] => 69 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14437325 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/437325
METHODS FOR REDUCING RISKS ASSOCIATED WITH HEART FAILURE AND FACTORS ASSOCIATED THEREWITH Oct 21, 2013 Abandoned
Array ( [id] => 9307067 [patent_doc_number] => 20140045741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-13 [patent_title] => 'Method Of Treating An Ocular Disease And Compositions Effective For Treating An Ocular Disease' [patent_app_type] => utility [patent_app_number] => 14/059035 [patent_app_country] => US [patent_app_date] => 2013-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4978 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14059035 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/059035
Method Of Treating An Ocular Disease And Compositions Effective For Treating An Ocular Disease Oct 20, 2013 Abandoned
Array ( [id] => 9560588 [patent_doc_number] => 20140178301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-26 [patent_title] => 'POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 14/055443 [patent_app_country] => US [patent_app_date] => 2013-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 21845 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14055443 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/055443
Polypeptides Oct 15, 2013 Issued
Array ( [id] => 10388014 [patent_doc_number] => 20150273021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-01 [patent_title] => 'COMPOSITIONS AND METHODS FOR SUSTAINED DELIVERY OF GLUCAGON-LIKE PEPTIDE (GLP-1) RECEPTOR AGONIST THERAPEUTICS' [patent_app_type] => utility [patent_app_number] => 14/434022 [patent_app_country] => US [patent_app_date] => 2013-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 31031 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14434022 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/434022
COMPOSITIONS AND METHODS FOR SUSTAINED DELIVERY OF GLUCAGON-LIKE PEPTIDE (GLP-1) RECEPTOR AGONIST THERAPEUTICS Oct 10, 2013 Abandoned
Array ( [id] => 10388003 [patent_doc_number] => 20150273010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-01 [patent_title] => 'HIGH-THROUGHPUT ASSAYS FOR HIV-1 ENVELOPE MATURATION AND NOVEL PEPTIDE INHIBITORS AGAINST HIV-1' [patent_app_type] => utility [patent_app_number] => 14/434622 [patent_app_country] => US [patent_app_date] => 2013-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 19853 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14434622 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/434622
HIGH-THROUGHPUT ASSAYS FOR HIV-1 ENVELOPE MATURATION AND NOVEL PEPTIDE INHIBITORS AGAINST HIV-1 Oct 8, 2013 Abandoned
Array ( [id] => 11479307 [patent_doc_number] => 09585828 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-07 [patent_title] => 'Proteoglycan-containing material' [patent_app_type] => utility [patent_app_number] => 14/046160 [patent_app_country] => US [patent_app_date] => 2013-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 16 [patent_no_of_words] => 15068 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14046160 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/046160
Proteoglycan-containing material Oct 3, 2013 Issued
Array ( [id] => 9205936 [patent_doc_number] => 20140005113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-02 [patent_title] => 'TREATMENT OF DISORDERS WITH ALTERED VASCULAR BARRIER FUNCTION' [patent_app_type] => utility [patent_app_number] => 14/022475 [patent_app_country] => US [patent_app_date] => 2013-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8614 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14022475 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/022475
TREATMENT OF DISORDERS WITH ALTERED VASCULAR BARRIER FUNCTION Sep 9, 2013 Abandoned
Array ( [id] => 10340449 [patent_doc_number] => 20150225454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-13 [patent_title] => 'TETRABRANCHED PEPTIDES AND ANALOGUES AS A NEW CLASS OF ANTIMICROBIALS AND THEIR PREPARATION THEREOF' [patent_app_type] => utility [patent_app_number] => 14/426822 [patent_app_country] => US [patent_app_date] => 2013-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12557 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14426822 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/426822
TETRABRANCHED PEPTIDES AND ANALOGUES AS A NEW CLASS OF ANTIMICROBIALS AND THEIR PREPARATION THEREOF Sep 8, 2013 Abandoned
Array ( [id] => 10317326 [patent_doc_number] => 20150202329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-23 [patent_title] => 'Methods and Composition for Detecting Intestinal Cell-Barrier Dysfunction' [patent_app_type] => utility [patent_app_number] => 14/424224 [patent_app_country] => US [patent_app_date] => 2013-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8351 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14424224 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/424224
Methods and Composition for Detecting Intestinal Cell-Barrier Dysfunction Sep 4, 2013 Abandoned
Array ( [id] => 9537143 [patent_doc_number] => 20140161786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-12 [patent_title] => 'Therapeutic compositions and related methods' [patent_app_type] => utility [patent_app_number] => 13/987770 [patent_app_country] => US [patent_app_date] => 2013-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12218 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13987770 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/987770
Therapeutic compositions and related methods Aug 28, 2013 Abandoned
Array ( [id] => 9263210 [patent_doc_number] => 20130345139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-26 [patent_title] => 'COMPOSITION FOR NUTRITION PURPOSES' [patent_app_type] => utility [patent_app_number] => 14/011924 [patent_app_country] => US [patent_app_date] => 2013-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2795 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14011924 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/011924
COMPOSITION FOR NUTRITION PURPOSES Aug 27, 2013 Abandoned
Array ( [id] => 10333535 [patent_doc_number] => 20150218539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-06 [patent_title] => 'METHODS OF USING THE CALCINEURIN A VARIANT CNAB1 FOR THE TREATMENT OF CARDIAC HYPERTROPHY' [patent_app_type] => utility [patent_app_number] => 14/422112 [patent_app_country] => US [patent_app_date] => 2013-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11798 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14422112 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/422112
METHODS OF USING THE CALCINEURIN A VARIANT CNAB1 FOR THE TREATMENT OF CARDIAC HYPERTROPHY Aug 15, 2013 Abandoned
Array ( [id] => 9162045 [patent_doc_number] => 20130310322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-21 [patent_title] => 'ISOLATED EXTRACELLULAR MATRIX MATERIAL INCLUDING SUBSEROUS FASCIA' [patent_app_type] => utility [patent_app_number] => 13/951631 [patent_app_country] => US [patent_app_date] => 2013-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12078 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13951631 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/951631
Isolated extracellular matrix material including subserous fascia Jul 25, 2013 Issued
Array ( [id] => 11814923 [patent_doc_number] => 09718865 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-01 [patent_title] => 'Sodium channel blocking peptides and the use thereof' [patent_app_type] => utility [patent_app_number] => 14/417394 [patent_app_country] => US [patent_app_date] => 2013-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15824 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14417394 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/417394
Sodium channel blocking peptides and the use thereof Jul 25, 2013 Issued
Array ( [id] => 10452013 [patent_doc_number] => 20150337026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-26 [patent_title] => 'PEPTIDE-BASED COMPOUNDS AND USES THEREOF TO TREAT BETA-AMYLOID ACCUMULATION' [patent_app_type] => utility [patent_app_number] => 14/416956 [patent_app_country] => US [patent_app_date] => 2013-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16482 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14416956 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/416956
Peptide-based compounds and uses thereof to treat beta-amyloid accumulation Jul 23, 2013 Issued
Array ( [id] => 9160915 [patent_doc_number] => 20130309192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-21 [patent_title] => 'Auristatin Compounds and Conjugates Thereof' [patent_app_type] => utility [patent_app_number] => 13/944561 [patent_app_country] => US [patent_app_date] => 2013-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 54290 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13944561 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/944561
Auristatin compounds and conjugates thereof Jul 16, 2013 Issued
Array ( [id] => 12302640 [patent_doc_number] => 09937235 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-04-10 [patent_title] => Lipidated peptides as anti-obesity agents [patent_app_type] => utility [patent_app_number] => 14/414034 [patent_app_country] => US [patent_app_date] => 2013-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 11990 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14414034 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/414034
Lipidated peptides as anti-obesity agents Jul 10, 2013 Issued
Array ( [id] => 9205937 [patent_doc_number] => 20140005114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-02 [patent_title] => 'Beta-Arrestin Effectors And Compositions And Methods Of Use Thereof' [patent_app_type] => utility [patent_app_number] => 13/926766 [patent_app_country] => US [patent_app_date] => 2013-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19510 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13926766 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/926766
β-arrestin effectors and compositions and methods of use thereof Jun 24, 2013 Issued
Menu